EXAS

Exact Sciences Corporation (EXAS) Financial Statements

Review Exact Sciences Corporation (EXAS) financials with server-rendered company data, supporting context and links to related investor research.

Annual revenue
$2.50B
Annual gross profit
$0.00
Annual operating income
$78.43M
Annual net income
$-204.15M
Annual free cash flow
$0.00
Total assets
$85.63M
Total liabilities
$341.68M
Shareholder equity
$3.15B

Exact Sciences Corporation (EXAS) Financial Statements research

The Exact Sciences Corporation financials page brings together the latest available annual and trailing figures for revenue, profitability, cash generation and balance-sheet strength. Comparing these measures across reporting periods can reveal whether operating performance and financial resilience are improving or weakening.

Revenue and earnings should be assessed together with free cash flow, assets, liabilities and debt ratios. A single figure is not a complete investment thesis, so use the linked analysis and valuation pages to place the reported results in context.